You have 9 free searches left this month | for more free features.

Androgens

Showing 26 - 50 of 734

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

PCOS, Vitamin D Trial in Dhaka (Vitamin D3, Placebo Oral Tablet)

Recruiting
  • PCOS
  • Vitamin D
  • Vitamin D3
  • Placebo Oral Tablet
  • Dhaka, Bangladesh
    BSMMU
Oct 29, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Paraphilia Trial in Paris (behavioral, other, biological, genetic)

Not yet recruiting
  • Paraphilia
  • Evaluation Scales
  • +4 more
  • Paris, France
    Hôpital Cochin
Oct 31, 2022

Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate)

Active, not recruiting
  • Congenital Adrenal Hyperplasia
  • Abiraterone acetate
  • Los Angeles, California
  • +3 more
Feb 22, 2022

Urinary Incontinence, Menopause Trial (Testosterone Enanthate, Placebo)

Withdrawn
  • Urinary Incontinence
  • Menopause
  • Testosterone Enanthate
  • Placebo
  • (no location specified)
Jul 18, 2022

Telomere Disease Trial run by the NHLBI (Danazol)

Recruiting
  • Telomere Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Statin Adverse Reaction Trial in Tunis (Atorvastatin 40 Mg Oral

Completed
  • Diabetes Mellitus, Type 2
  • +5 more
  • Atorvastatin 40 Mg Oral Tablet
  • Tunis, Tunisia
    University Hospital La Rabta
Apr 7, 2023

Treatment of Hypertrichosis With Intense Pulsed Light

Not yet recruiting
  • Hypertrichosis
  • Hirsutism - Hypertrichosis
  • Intense pulsed light
  • Umeå, Västerbotten, Sweden
    Norrlands University Hospital
Mar 20, 2023

Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Androgen suppression plus radiation therapy
  • Montreal, Quebec, Canada
  • +1 more
Jan 30, 2023

Hypertension, Hyperlipidemias Trial in New Haven (Atorvastatin, )

Withdrawn
  • Hypertension
  • Hyperlipidemias
  • New Haven, Connecticut
    Yale School of Medicine
Oct 31, 2022

Dissecting Androgen Excess and Metabolic Dysfunction in

Recruiting
  • Polycystic Ovary Syndrome
  • Women with polycystic ovary syndrome
  • Birmingham, West Midlands, United Kingdom
    Wellcome Trust Clinical Research Facility
Feb 22, 2022

SMART Protocol vs Antagonist Protocol in IVF

Active, not recruiting
  • Diminished Ovarian Reserve
    • Montreal, Quebec, Canada
      Clinique Ovo
    Dec 22, 2022

    Pharmacokinetics, Hormone Deficiency Trial in Santiago (Dehydroepiandrosterone 2.2 g, Dehydroepiandrosterone 1.5 g/Testosterone

    Completed
    • Pharmacokinetics
    • Hormone Deficiency
    • Dehydroepiandrosterone 2.2 g
    • +4 more
    • Santiago, Chile
      Instituto de Investigación Materno Infantil (IDIMI) - Maternidad
    May 27, 2019

    Prostate Cancer Trial (iMAB, cMAB)

    Not yet recruiting
    • Prostate Cancer
    • (no location specified)
    Jul 26, 2023

    Aqueous Tear Deficiency, Meibomian Gland Dysfunction of Bilateral Eyes (Disorder) Trial in Fullerton (Testosterone gel 4.5%,

    Recruiting
    • Aqueous Tear Deficiency
    • Meibomian Gland Dysfunction of Bilateral Eyes (Disorder)
    • Testosterone gel 4.5%
    • Vehicle gel
    • Fullerton, California
      Southern California College of Optometry at Marshall B. Ketchum
    Nov 29, 2023

    Metastatic Hormone-sensitive Prostate Cancer Trial in United States (androgen-deprivation therapy, docetaxel)

    Active, not recruiting
    • Metastatic Hormone-sensitive Prostate Cancer
    • Anchorage, Alaska
    • +342 more
    Jan 29, 2023

    High-risk Prostate Cancer, Neoadjuvant Therapy Trial in Shanghai (Abiraterone acetate, Fluzoparib, Prednisone)

    Recruiting
    • High-risk Prostate Cancer
    • Neoadjuvant Therapy
    • Abiraterone acetate
    • +4 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 6, 2022

    Innate Immune Cells Trial in Hershey (Cogni.Q, Placebo)

    Recruiting
    • Innate Immune Cells
    • Cogni.Q
    • Placebo
    • Hershey, Pennsylvania
      Penn State College of Medicine
    Feb 11, 2022

    Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Columbus (Arm I Soy Bread, Arm II Soy-Almond Bread)

    Active, not recruiting
    • Recurrent Prostate Cancer
    • Stage IV Prostate Cancer
    • Arm I Soy Bread
    • Arm II Soy-Almond Bread
    • Columbus, Ohio
      The Ohio State University Medical Center
    Apr 29, 2022

    Invasive Ductal Breast Carcinoma Trial in Clamart (Degarelix injection(s))

    Completed
    • Invasive Ductal Breast Carcinoma
    • Degarelix injection(s)
    • Clamart, France
      Hôpital Antoine Béclère
    Sep 26, 2022

    Prostate Cancer, Biochemical Recurrence Trial in Nanjing (Rezvilutamide, Androgen deprivation therapy (ADT), SRT)

    Recruiting
    • Prostate Cancer
    • Biochemical Recurrence
    • Nanjing, Jiangsu, China
    • +1 more
    Mar 2, 2023

    Preserving Fertility After Colorectal Cancer Study

    Recruiting
    • Colorectal Cancer
      • Nashville, Tennessee
        Vanderbilt-Ingram Cancer Center
      Feb 1, 2022

      Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis

      Recruiting
      • Polymyalgia Rheumatica (PMR)
      • Giant Cell Arteritis (GCA)
      • Data collection for cellular analyses (Immune subset composition, GCR expression, in vitro steroid responsiveness)
      • +3 more
      • Basel, Switzerland
        Department of Rheumatology University Hospital Basel
      Aug 2, 2022